생세포 캡슐화 시장 - 세계 산업 규모, 점유율, 동향, 경쟁, 기회, 예측 : 폴리머 유형별, 용도별, 기술별, 지역별, 경쟁별(2020-2030년)
Live Cell Encapsulation Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Polymer Type, By Application, By Technique, By Region and Competition, 2020-2030F
상품코드:1778987
리서치사:TechSci Research
발행일:2025년 07월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 생세포 캡슐화 시장은 2024년에 2억 5,400만 달러로 평가되었고 예측 기간 중 연평균 복합 성장률(CAGR)은 26.62%를 나타낼 전망이며, 2030년에는 10억 4,700만 달러에 이를 것으로 예측됩니다.
이는 세포 캡슐화 기술의 유효성을 향상시키는 연구개발 증가, 생세포 캡슐화 제품 개발을 지원하는 정부 및 민간 투자 증가 등의 요인에 기인합니다. 생세포 캡슐화는 살아있는 세포를 물질이나 코팅으로 감싸는 것을 포함하는 생명공학 기술입니다. 캡슐화에는 리포좀, 하이드로겔, 마이크로 캡슐 등 다양한 재료가 사용됩니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
2억 5,400만 달러
시장 규모 : 2030년
10억 4,700만 달러
CAGR : 2025-2030년
26.62%
급성장 부문
키토산
최대 시장
북미
또한, 생세포 캡슐화는 생리활성물질과 세포의 조절된 방출을 가능하게 하기 때문에 세포치료에서 중요한 역할을 하는 것으로 알려져 있으며, 이는 전 세계적으로 세포치료 증가와 함께 시장 성장을 가속할 것으로 예측됩니다.
시장 성장 촉진요인
세포치료가 필요한 만성질환 증가
주요 시장 이슈
면역거부반응과 섬유성 과증식증
주요 시장 동향
재생의료 및 조직공학에서 캡슐화 활용 증가
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 생세포 캡슐화 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
폴리머 유형별(알긴산염, 키토산, 황산 셀룰로오스, 기타)
용도별(약물전달, 재생의료, 세포 이식, 프로바이오틱스)
기술별(단순적하법, 정전적하법, 동축기류법)
기업별(2024년)
지역별
시장 맵
제6장 아시아태평양의 생세포 캡슐화 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
한국
일본
호주
제7장 유럽의 생세포 캡슐화 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 북미의 생세포 캡슐화 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제9장 남미의 생세포 캡슐화 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 생세포 캡슐화 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
인수합병(M&A)
제품 개발
제13장 Porter의 Five Forces 분석
업계내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협/서비스
제14장 세계의 생세포 캡슐화 시장 : SWOT 분석
제15장 경쟁 구도
Merck KGaA
Sphere Bio.
Vertex Pharmaceuticals Incorporated
Unchained Labs.
BIO INX
Algorae Pharmaceuticals Ltd
Eli Lilly and Company
Isogen Lifescience B.V.
Diatranz Otsuka Ltd
PHAXIAM Therapeutics S.A.
제16장 전략적 제안
제17장 회사 소개 및 면책조항
LSH
영문 목차
영문목차
Global Live Cell Encapsulation Market was valued at USD 254 million in 2024 and is expected to reach USD 1047 million by 2030 with a CAGR of 26.62% during the forecast period. This can be attributed to factors such as growing research & development in improving the effectiveness of cell encapsulation technologies, along with the rise in governmental and private investments supporting live cell encapsulated product development. Live cell encapsulation is a bioengineering technology which includes encasing living cells with a material or coating. A distinct variety of materials are used for the encapsulation such as liposomes, hydrogels, and microcapsules.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 254 Million
Market Size 2030
USD 1047 Million
CAGR 2025-2030
26.62%
Fastest Growing Segment
Chitosan
Largest Market
North America
Moreover, live cell encapsulation is found to have significant importance in cell therapies as it allows a controlled release of bioactive material or cells and thereby is anticipated to bolster market growth with rise in cell therapies across the globe.
Key Market Drivers
Increasing Incidence of Chronic Diseases Requiring Cell-Based Therapies
One of the primary drivers fueling the live cell encapsulation market is the rising prevalence of chronic and non-communicable diseases (NCDs) such as diabetes, cancer, and neurological disorders. Encapsulation technology allows for the delivery of therapeutic cells, such as pancreatic islet cells, which are crucial for insulin production in type 1 diabetes. According to the World Health Organization (WHO), NCDs are responsible for over 74% of all global deaths, and nearly 422 million people globally have diabetes. A significant portion of this population requires lifelong insulin therapy, and live cell encapsulation offers a transformative solution through potential curative therapies.
The ability of encapsulated cells to provide sustained therapeutic benefit without provoking an immune response has made this technique increasingly important for regenerative medicine. Governments in high-burden countries have begun investing in regenerative medicine research. For example, the U.S. National Institutes of Health (NIH) allocated nearly $2 billion toward cell-based therapy and regenerative medicine research in recent years. Similarly, the European Commission supports cell-based innovation through its Horizon Europe program. These investments indicate growing public sector endorsement for technologies like cell encapsulation, particularly in chronic disease management.
Key Market Challenges
Immune Rejection and Fibrotic Overgrowth
Despite technological progress, one of the most persistent challenges in the live cell encapsulation market is immune rejection and fibrotic response that can limit the functional lifespan of encapsulated cells. While the encapsulation membrane is designed to shield cells from immune surveillance, over time the body may still recognize the foreign material and initiate fibrotic encapsulation, which leads to reduced nutrient exchange and eventual cell death.
This issue is particularly problematic in long-term applications such as pancreatic islet transplantation for diabetes or encapsulated neural cells for treating Parkinson's disease. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), clinical studies of islet transplantation show promising early results but often experience a decline in cell function over time due to immune-mediated encapsulation or fibrosis. This has limited the wide-scale clinical adoption of encapsulated cell therapies, especially in countries with stringent medical device approval processes.
Key Market Trends
Rising Use of Encapsulation in Regenerative Medicine and Tissue Engineering
A significant trend shaping the live cell encapsulation market is its expanding role in regenerative medicine and tissue engineering applications. Researchers are increasingly using encapsulated cells not only for drug delivery but also to repair or regenerate damaged tissues, including cartilage, cardiac muscle, and neuronal structures. The biocompatibility and immune-isolating properties of encapsulated cells make them highly suitable for transplantation in environments where immune rejection is a concern.
Governmental support for regenerative medicine is growing globally. For example, the U.S. 21st Century Cures Act allocates billions toward advancing regenerative therapies, and the European Union's Horizon Europe program continues to fund cross-border collaborative research in tissue regeneration. Encapsulation plays a central role in these initiatives, offering controlled, localized cell delivery and minimizing systemic side effects.
Key Market Players
Merck KGaA
Sphere Bio.
Vertex Pharmaceuticals Incorporated
Unchained Labs.
BIO INX
Algorae Pharmaceuticals Ltd
Eli Lilly and Company
Isogen Lifescience B.V.
Diatranz Otsuka Ltd
PHAXIAM Therapeutics S.A.
Report Scope:
In this report, the Global Live Cell Encapsulation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Live Cell Encapsulation Market, By Polymer Type:
Alginate
Chitosan
Cellulose Sulfate
Others
Live Cell Encapsulation Market, By Application:
Drug Delivery
Regenerative Medicine
Cell Transplantation
Probiotics
Live Cell Encapsulation Market, By Technique:
Simple Dripping
Electrostatic Dripping
Coaxial Airflow
Live Cell Encapsulation Market, By Region:
North America
United States
Mexico
Canada
Europe
France
Germany
United Kingdom
Italy
Spain
Asia-Pacific
China
India
South Korea
Japan
Australia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Live Cell Encapsulation Market.
Available Customizations:
Global Live Cell Encapsulation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered.
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Live Cell encapsulation Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Polymer Type (Alginate, Chitosan, Cellulose Sulfate and Others)
5.2.2. By Application (Drug Delivery, Regenerative Medicine, Cell Transplantation and Probiotics)
5.2.3. By Technique (Simple Dripping, Electrostatic Dripping and Coaxial Airflow
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. Asia-Pacific Live Cell encapsulation Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Polymer Type
6.2.2. By Application
6.2.3. By Technique
6.2.4. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Live Cell encapsulation Market Outlook.
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Polymer Type
6.3.1.2.2. By Application
6.3.1.2.3. By Technique
6.3.2. India Live Cell encapsulation Market Outlook.
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Polymer Type
6.3.2.2.2. By Application
6.3.2.2.3. By Technique
6.3.3. South Korea Live Cell encapsulation Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Polymer Type
6.3.3.2.2. By Application
6.3.3.2.3. By Technique
6.3.4. Japan Live Cell encapsulation Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Polymer Type
6.3.4.2.2. By Application
6.3.4.2.3. By Technique
6.3.5. Australia Live Cell encapsulation Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Polymer Type
6.3.5.2.2. By Application
6.3.5.2.3. By Technique
7. Europe Live Cell encapsulation Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Polymer Type
7.2.2. By Application
7.2.3. By Technique
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Live Cell encapsulation Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Polymer Type
7.3.1.2.2. By Application
7.3.1.2.3. By Technique
7.3.2. Germany Live Cell encapsulation Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Polymer Type
7.3.2.2.2. By Application
7.3.2.2.3. By Technique
7.3.3. United Kingdom Live Cell encapsulation Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Polymer Type
7.3.3.2.2. By Application
7.3.3.2.3. By Technique
7.3.4. Italy Live Cell encapsulation Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Polymer Type
7.3.4.2.2. By Application
7.3.4.2.3. By Technique
7.3.5. Spain Live Cell encapsulation Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Polymer Type
7.3.5.2.2. By Application
7.3.5.2.3. By Technique
8. North America Live Cell encapsulation Market Outlook.
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Polymer Type
8.2.2. By Application
8.2.3. By Technique
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Live Cell encapsulation Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Polymer Type
8.3.1.2.2. By Application
8.3.1.2.3. By Technique
8.3.2. Mexico Live Cell encapsulation Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Polymer Type
8.3.2.2.2. By Application
8.3.2.2.3. By Technique
8.3.3. Canada Live Cell encapsulation Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Polymer Type
8.3.3.2.2. By Application
8.3.3.2.3. By Technique
9. South America Live Cell encapsulation Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Polymer Type
9.2.2. By Application
9.2.3. By Technique
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Live Cell encapsulation Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Polymer Type
9.3.1.2.2. By Application
9.3.1.2.3. By Technique
9.3.2. Argentina Live Cell encapsulation Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Polymer Type
9.3.2.2.2. By Application
9.3.2.2.3. By Technique
9.3.3. Colombia Live Cell encapsulation Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Polymer Type
9.3.3.2.2. By Application
9.3.3.2.3. By Technique
10. Middle East and Africa Live Cell encapsulation Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Polymer Type
10.2.2. By Application
10.2.3. By Technique
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Live Cell encapsulation Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Polymer Type
10.3.1.2.2. By Application
10.3.1.2.3. By Technique
10.3.2. Saudi Arabia Live Cell encapsulation Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Polymer Type
10.3.2.2.2. By Application
10.3.2.2.3. By Technique
10.3.3. UAE Live Cell encapsulation Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Polymer Type
10.3.3.2.2. By Application
10.3.3.2.3. By Technique
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Developments
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products/Services
14. Global Live Cell encapsulation Market: SWOT Analysis
